drugset / Trial / NCT02127749

The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia

NCT02127749

RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to determine whether treatment with antibiotics, which harm the gut flora, causes the immune system to be less effective.

Timeline

Start
2014-06
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 500 mg Oral
Subject Metronidazole Small molecule 500 mg Oral
Subject Vancomycin Other / unclassified 500 mg Oral

Indications

No indication recorded.